Dr. Amy D Cummings is a pharmacist who is specialized in Pharmacotherapy in Topeka, Kansas. Patients can reach her at 2200 Sw Gage Blvd, Pharmacy Services 119, Topeka or contact her on 785-350-3111. Active license number of Dr. Amy D Cummings is 2011027490 for Pharmacotherapy in Missouri. Dr. Amy D Cummings is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Dr. Amy D Cummings speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Amy D Cummings are as mentioned below.
NPI Number:
1265719611
NPI Enumeration Date:
14 Nov, 2011
NPI Last Update On:
13 Jul, 2012
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Amy D Cummings are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
2011027490
Missouri
Primary
Pharmacist
2011027490
Missouri
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
4801 E Linwood Blvd, Kansas City, Missouri
Zip:
64128-2226
Phone Number:
816-922-2500
Fax Number:
--
Patients can reach Dr. Amy D Cummings at 2200 Sw Gage Blvd, Pharmacy Services 119, Topeka, Kansas or can call on phone at 785-350-3111.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.